한국식품영양과학회지 (Journal of the Korean Society of Food Science and Nutrition)

  • 제23권6호
  • /
  • Pages.922-926
  • /
  • 1994
  • /
  • 1226-3311(pISSN)
  • /
  • 2288-5978(eISSN)
한국식품영양과학회 (The Korean Society of Food Science and Nutrition)
권호 표지

Sarcoma-180 유발 생쥐에 대한 Cyclophosphamide, Picibanil 및 Tubercin-3의 투여효과

Anti-Tumor Effect of Cyclophosphamide, TUbercin-3 , and Picibanil on Sarcoma-180 Bearing Mice

  • 이인선 (계명대학교 식품가공학과) ;
  • 김혁일 (계명대학교 식품가공학과) ;
  • 황기 (계명대학교 식품가공학과)
  • Lee, In-Seon (Dept. of Food Science and Technology, Keimyung University) ;
  • Kim, Hyuk-Il (Dept. of Food Science and Technology, Keimyung University) ;
  • Whang, Key (Dept. of Food Science and Technology, Keimyung University)
  • 발행 : 1994.12.01
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

This study was carried out to detemrine the efficacy of combined treatment of cyclophosphamide with tubericin-3 and or picibanil. One hundred sixty sarcoma-180 bearing mice were divided eight groups. Each group received saline, tubercin-3, picibanil , and cyclophosphamide along and/or received cyclophosphamide with tubercin-3 , with picibanil or with both tubercin-3 and picinanil, respectively.Average surviving time of each group of animals was as follows ; control was 10.9days, tubercin-3 was 15.1 days. picibanil was 12.6 days, and cylophosphamide was 17.9 days, In combined therapyy that cylophosphamide injected with tubercin-3 , the surviving time was 26.8 days an din the case of other therapy that cyclophosphamide injected with tubercin-3, the surviving time was 26.8 days an din the case of other therapy that cyclophosphamide injected with picibanil, the surviving time was 21.9 day and cyclophosphamide treated with both turbercin03 and picibanil, the surviving time was found to be 18.2 days, conclusively , the therapeutic potentiation seemed to be extended when combined tretment of the chemotherapeutics cyclophosphamide with either one of immunotherapeutics tubericin-3 or picibanil was tried, Combinatin of tubercin-3 and picibanil showed to be atagonistic each other. Yield of ascites fluid were determined 7 days after injectino of sarcoma-180 ascites tumor cells. Adminitration of cyclophosphamide, tubercin-3 , and picibanil alone and their various combinations reduced the yield of ascites fluid except for picibanil group.

키워드

참고문헌

  1. Nature v.184 Effect of Bacillus Calmette-Guerin infection on transplanted tumor in the mouse Old,L.J.;Clark,D.A.;Benacerraf,B.
  2. Proc. Soc. Exp. Biol. Med. v.62 Accelerated rejection of male skin isografts by female C-57 BL mice infected with Bacillus Calmette-Guerin Balner,H.;Old,L.T.;Clarke,D.A.
  3. J. Reticuloendothel. Soc. v.10 Immunological studies with human neoplasms Morton,D.L.
  4. Natl. Cancer Inst. Monogr. v.39 BCG and cancer immunotherapy Mathe,G.
  5. New Eng. J. Med. v.290 BCG and cancer Bast,J.;Zbar,B.;Borsos,T.;Rapp,H.T.
  6. J. Exp. Med. v.119 Studies on the heterologous immuno-genecity of a methanol-insoluble fraction of attenuated tubercle bacilli(BCG) Weiss,D.W.;Bonhag,R.S.;Parks,J.A.
  7. J. Bacteriol. v.96 Fraction of mycobacterial cell wall Azuma,I.;Yammamura,Y.;Fukushi,K.
  8. 대한의학협회지 v.17 결핵균체에서 추출한 단백복합물질 tubercin-3의 등전점 분획상과 그 물질의 항암 결과에 관하여 정태호
  9. Ann. Rev. Med. v.28 BCG as adjuvant immuno-therapy for neoplasia Hersh,E.M.;Gutterman,J.U.;Mavligit,G.M.
  10. Japan J. Exp. Med. v.45 Experimental anticancer studies part Ⅲ. On the influence of living hemolytic steptococci carcinoma in mice Koshimura,S.;Murasawa,K.;Nakagawa,E.;Ueda,M.;Barrdo,Y.;Hirata,R.
  11. Cancer Chemother. Res. v.56 Tumor-inhibitory effect of a streptococcal preparation(NSC-B116209) Sakurai,Y.;Tsukagoshi,S.;Satoh,H.;Akiba,T.;Suzuki,S.;Takagaki,Y.
  12. Gann v.67 Inhibition of tumor growth in vivo and in vitro by macro phages from rate treated with a streptococcal preparation, OK-432 Ishii,Y.;Yamaska,H.;Toh,K.;Kikuchi,K.
  13. Med. Clin. North. Am. v.60 Chemoimmunotherapy of human solid tumors Maulight,G.M.;Hersh,E.M.
  14. Biosci. Biotech. Biochem. v.56 Chalcone tetramers, lophirachalcone and alatachacone, from Lophira alata as possible anti-tumor promoters Murakami,A.;Tanaka,S.;Ohigashi,H.;Koshimizu,K.
  15. Immunological Techniques Production of large amounts of antibodies, nonspecific immunoglobulins, and other serum proteins in ascitic fluids of individual mice and guinea pigs Tung,A.S.
  16. Indian J. Med. Res. v.92 In vitro studies on the effect of certatin natural products against hepatitis B virus Mohrotra,R.;Rawat,S.;Kulshreshtha,D.K.;Patnait,G.K.;Dhawan,B.N.
  17. Cancer Res. v.41 The role of the reticuloendothelial system in the host reaction to neoplasia Old,L.J.;Benacerraf,B.;Clark,D.A.;Carswell,E.A.;Stocket,E.
  18. Surgery v.78 Immunological factors which influence responese to immunotherapy in malignant melanoma Morton,D.L.;Eilber,F.R.;Malmgren,R.A.
  19. Lancet v.21 Active immunotherapy for acute lymphoblastic leukemia Mathe,G.;Amiel,J.L.;Schwarzenberg,L.;Schneider,M.;Cttan,A.;Schlumberger,J.R.;Hayat,M.;de Vassa,F.
  20. Cancer Treat. Rep. v.60 Studies on the disposition of cyclophosphamide in tumor bearing mice by means of gas chromatography-chemical ionization-mass fragmentography Pantarotto,C.;Martini,A.;Belvedere,G.